Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities

Eur J Med Chem. 2009 Jan;44(1):109-16. doi: 10.1016/j.ejmech.2008.03.009. Epub 2008 Mar 27.

Abstract

A series of 2-aryl-naphtho[1,2-d]oxazole derivatives have been synthesized and evaluated for PTP-1B inhibitory activity. The compounds have been screened in vivo for antidiabetic activity under sucrose loaded model (SLM), sucrose-challenged streptozotocin-induced diabetic rat model (STZ-S) and db/db mice model. Compounds 8 and 12 have shown promising PTP-1B inhibitory activity, significant antidiabetic activity, moderate lipid and triglyceride lowering activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / drug therapy*
  • Enzyme Inhibitors
  • Hypoglycemic Agents / chemistry*
  • Hypoglycemic Agents / pharmacology
  • Lipids / blood
  • Mice
  • Oxazoles / chemistry*
  • Oxazoles / pharmacology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
  • Rats
  • Structure-Activity Relationship
  • Triglycerides / blood

Substances

  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • Lipids
  • Oxazoles
  • Triglycerides
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Ptpn1 protein, mouse